In this study, we used fixed cell staining and cellular extraction spot blotting to analyze cancer type specific changes in the PI phosphorylation profile of hormone receptor positive (HR+), HER2+, and triple negative breast cancer (TNBC) cells as a function of serum glucose concentrations. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.